Ocular Demodex folliculorum: prevalence and associated symptoms in an Irish population
Purpose To investigate the prevalence of ocular Demodex folliculorum (DF) in an Irish population. To validate a modified Ocular Surface Disease Index questionnaire and employ it to evaluate the relationship between dry eye symptoms and the presence of DF. Methods One hundred and fifty-six subjects w...
Gespeichert in:
Veröffentlicht in: | International ophthalmology 2019-02, Vol.39 (2), p.405-417 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Purpose
To investigate the prevalence of ocular
Demodex folliculorum
(DF) in an Irish population. To validate a modified Ocular Surface Disease Index questionnaire and employ it to evaluate the relationship between dry eye symptoms and the presence of DF.
Methods
One hundred and fifty-six subjects were enrolled in an epidemiological cross-sectional prevalence study. Each subject completed a novel questionnaire on ocular symptoms and was assessed for the presence of DF. Data was analysed to assess prevalence and to search for significant links between each symptom and DF.
Results
An overall prevalence of 68% was found. Total mean number of DF found on microscopic examination was 3.83 mites per subject (range 0–25). The presence of symptoms was higher among individuals with DF (
P
= 0.04). Itch was found to be the symptom most significantly associated with the presence and number of DF (
P
= 0.025 and
P
= 0.035, respectively). The questionnaire showed good internal consistency (Cronbach’s alpha;
α
> 0.7) and good reliability (Intra-class Correlation Co-efficient; ICC > 0.7). The sensitivity and specificity of a positive symptom result using the questionnaire were 70.8% and 46.9%, respectively.
Conclusion
There is a strong association between the prevalence of DF and symptoms, in particular itchy eyes. However, not all patients with DF will be symptomatic. The newly developed questionnaire is a reliable instrument for measuring change in symptoms over a period of time and suitable for observing patient reported outcomes in interventional treatment studies. |
---|---|
ISSN: | 0165-5701 1573-2630 |
DOI: | 10.1007/s10792-018-0826-1 |